Marios Politis

Marios Politis is a board-certified Neurologist and the Director of Mireille Gillings Neuroimaging Centre at the University of Exeter. He has obtained an MSc, the DIC and a PhD in Clinical Neurosciences from Imperial College London.

This is the blog of Professor Marios Politis, Professor of Neurology, the Director of Neurodegeneration Imaging Group (NIG) and the Director of Mireille Gillings Neuroimaging Centre at the University of Exeter. This blog will explore the professional life of Marios, covering a range of topics from his conception and development of the Neurodegeneration Imaging Group (NIG), the many accolades he has received for his work and his industry experience.


Marios Politis is an expert in neurological disorders and has dedicated his career to this field. He has received significant levels of funding for his work from charities, foundations and industry.

Formerly based at Imperial College London and King’s College in London, in 2019, Professor Marios Politis, along with the NIG, relocated to the University of Exeter, which has sites both in Exeter itself and London.

The new homes of the Group are the Translation and Innovation Hub in London and the Mireille Gillings Neuroimaging Centre at Exeter, which are state-of-the-art facilities promoting multi- and interdisciplinary research and development.


Marios Politis bio pic

Marios has spent many years in a teaching capacity at university level, keen to pass on his expertise in neurology to the next generation; he has received several awards and much praise for the excellence of his delivery of education to undergraduate and post-graduate students studying both medical and non-medical disciplines.

Marios has been invited to talk in numerous international conferances such as the congresses organised by the Movement Disorder Society, Amercian Academy of Neurology and many others.  Events such as the Congress are vital, due to the complexity of the field of neurology, as they allow members to address current controversies around the subject and share understanding.


In 2016, he was elected Fellow of the European Academy of Neurology for outstanding contribution in neurodegenerative research. In 2017, Marios’ work was recognised by the American Academy of Neurology with the Jon Stolk Award in Movement Disorders. Also in 2017, Marios was elected Fellow of Royal College of Physicians.


Marios Politis has been the recipient of a plethora of awards to recognise his clinical research and clinical research excellence in the field of neurology. These include a research achievement award bestowed by the MRC in 2010, the Movement Disorder Society Award for Outstanding and Innovative Clinical Research in 2012

Awards also include, the IMPETus Award for Innovative and Outstanding PET Molecular Imaging Research, (which he was given in 2013, 2014, 2015, and 2016) and the PET Investigator Award, given by the Society of Nuclear Medicine and Molecular Imaging in 2015.

Marios Politis

The Royal College of Physicians: From 1518 to the Present Day

The Royal College of Physicians was founded in 1518 through a Royal Charter by King Henry VIII, making it the oldest medical college in England. Over the centuries, it has often played a significant role in shaping public health and raising standards. High Society...
Marios Politis

The Impact of the ‘De-Risking’ Research Strategy on Parkinson’s Disease Drug Development

Since its inception, the Michael J. Fox Foundation for Parkinson’s Research (MJFF) has deployed a ‘de-risking’ research strategy to drive forward the development of new Parkinson’s disease treatments. The strategy is built around the core idea that developing even a...
Marios Politis

The Common Signs of Dementia

Dementia can present itself very differently from one patient to the next. As Professor of Neurology Marios Politis knows from experience, symptoms that severely affect one person may be less noticeable in another. However, there are certain signs and symptoms that...
Marios Politis

Managing Alzheimer’s With Pet Therapy

Dementia is a chronic condition that gradually impairs memory and other cognitive functions, social behaviour and the ability to perform daily tasks. Although doctors cannot prevent disease progression with any medication, most treatments aim to reduce the patient's...
Marios Politis

The Importance of Maintaining Good Bone Health with Parkinson’s Disease

With 54 million people over the age of 50 being at risk of breaking a bone in the US alone according to the National Osteoporosis Foundation, everyone should be concerned about their bone health. In particular, those with Parkinson’s disease should pay special...
Marios Politis

The Work of the International Parkinson and Movement Disorder Society

The International Parkinson and Movement Disorder Society is made up of more than 11,000 scientists, clinicians and other healthcare professionals. The aim of the society is to improve the care of patients with movement disorders through research and education....
Marios Politis

Deep Brain Stimulation

Deep brain stimulation (DBS) entails implanting electrodes within certain areas of the brain. The electrical impulses these electrodes produce can regulate abnormal impulses or can affect certain chemicals and cells within the brain. DBS can be used to treat...
Marios Politis

Speciality Speaker Marios Politis: Controversies in Neurology

Marios Politis is a Professor of Neurology, Consultant Neurologist, the Director of the Neurodegeneration Imaging Group and the Director of the Mireille Gillings Neuroimaging Centre at the University of Exeter. In his role as a speciality speaker, Marios addressed a...
Marios Politis

Marios Politis: Working in Education

Marios Politis is a Professor of Neurology, Consultant Neurologist, the Director of Neurodegeneration Imaging Group and the Director of Mireille Gillings Neuroimaging Centre at the University of Exeter. Pursuing a Career in Neurology Educating the neurologists of the...
Marios Politis

What is Parkinson’s Disease?

Parkinson’s Disease (PD) is a neurodegenerative condition that affects both the elderly and - in rarer cases - younger patients. Onset symptoms vary dramatically between individuals, but common warning signs affect the limbs and movement. Involuntary movement, tremors...